Jump to content

User:Immcarle188/Macrophage

From Wikipedia, the free encyclopedia

Article Draft

[edit]

Lead

[edit]

Role in Innate Immune Response

[edit]

When a pathogen invades, tissue resident macrophages are among the first cells to respond.[1] Two of the main roles of the tissue resident macrophages are to phagocytose incoming antigen and to secrete proinflammatory cytokines that induce inflammation and recruit other immune cells to the site.[2]

Phagocytosis of Pathogens

[edit]

Macrophages can internalize antigens through receptor-mediated phagocytosis.[3] Macrophages have a wide variety of pattern recognition receptors (PRRs) that can recognize microbe-associated molecular patterns (MAMPs) from pathogens. Many PRRs, such as toll-like receptors (TLRs), scavenger receptors (SRs), C-type lectin receptors, among others, recognize pathogens for phagocytosis.[3] Macrophages can also recognize pathogens for phagocytosis indirectly through opsonins, which are molecules that attach to pathogens and mark them for phagocytosis.[4] Opsonins can cause a stronger adhesion between the macrophage and pathogen during phagocytosis, hence opsonins tend to enhance macrophages’ phagocytic activity.[5] Both complement proteins and antibodies can bind to antigens and opsonize them. Macrophages have complement receptor 1 (CR1) and 3 (CR3) that recognize pathogen-bound complement proteins C3b and iC3b, respectively, as well as fragment crystallizable γ receptors (FcγRs) that recognize the fragment crystallizable (Fc) region of antigen-bound immunoglobulin G (IgG) antibodies.[4][6] When phagocytosing and digesting pathogens, macrophages go through a respiratory burst where more oxygen is consumed to supply the energy required for producing reactive oxygen species (ROS) and other antimicrobial molecules that digest the consumed pathogens.[2][7]

Cytokine Secretion

[edit]

Recognition of MAMPs by PRRs can activate tissue resident macrophages to secrete proinflammatory cytokines that recruit other immune cells. Among the PRRs, TLRs play a major role in signal transduction leading to cytokine production.[3] The binding of MAMPs to TLR triggers a series of downstream events that eventually activates transcription factor NF-κB and results in transcription of the genes for several proinflammatory cytokines, including IL-1β, IL-6, TNF-α, IL-12B, and type I interferons such as IFN-α and IFN-β.[8] Systemically, IL-1β, IL-6, and TNF-α induce fever and initiate the acute phase response in which the liver secretes acute phase proteins.[1][2][9] Locally, IL-1β and TNF-α cause vasodilation, where the gaps between blood vessel epithelial cells widen, and upregulation of cell surface adhesion molecules on epithelial cells to induce leukocyte extravasation.[1][2]

Neutrophils are among the first immune cells recruited by macrophages to exit the blood via extravasation and arrive at the infection site.[9] Macrophages secrete many chemokines such as CXCL1, CXCL2, and CXCL8 (IL-8) that attract neutrophils to the site of infection.[1][9] After neutrophils have finished phagocytosing and clearing the antigen at the end of the immune response, they undergo apoptosis, and macrophages are recruited from blood monocytes to help clear apoptotic debris.[10]

Macrophages also recruit other immune cells such as monocytes, dendritic cells, natural killer cells, basophils, eosinophils, and T cells through chemokines such as CCL2, CCL4, CCL5, CXCL8, CXCL9, CXCL10, and CXCL11.[1][9] Along with dendritic cells, macrophages help activate natural killer (NK) cells through secretion of type I interferons (IFN-α and IFN-β) and IL-12. IL-12 acts with IL-18 to stimulate the production of proinflammatory cytokine interferon gamma (IFN-γ) by NK cells, which serves as an important source of IFN-γ before the adaptive immune system is activated.[9][11] IFN-γ enhances the innate immune response by inducing a more aggressive phenotype in macrophages, allowing macrophages to more efficiently kill pathogens.[9]

Some of the T cell chemoattractants secreted by macrophages include CCL5, CXCL9, CXCL10, and CXCL11.[1]

Role in Adaptive Immune Response

[edit]

Interactions with CD4+ T Helper Cells

[edit]

Macrophages are professional antigen presenting cells (APC), meaning they can present peptides from phagocytosed antigens on major histocompatibility complex (MHC) II molecules on their cell surface for T helper cells.[12] Macrophages are not primary activators of naïve T helper cells that have never been previously activated since tissue resident macrophages do not travel to the lymph nodes where naïve T helper cells reside.[13][14] Although macrophages are also found in secondary lymphoid organs like the lymph nodes, they do not reside in T cell zones and are not effective at activating naïve T helper cells.[13] The macrophages in lymphoid tissues are more involved in ingesting antigens and preventing them from entering the blood, as well as taking up debris from apoptotic lymphocytes.[13][15] Therefore, macrophages interact mostly with previously activated T helper cells that have left the lymph node and arrived at the site of infection or with tissue resident memory T cells.[14]

Macrophages supply both signals required for T helper cell activation: 1) Macrophages present antigen peptide-bound MHC class II molecule to be recognized by the corresponding T cell receptor (TCR), and 2) recognition of pathogens by PRRs induce macrophages to upregulate the co-stimulatory molecules CD80 and CD86 (also known as B7) that binds to CD28 on T helper cells to supply the co-stimulatory signal.[9][12] These interactions allow T helper cells to achieve full effector function and provide T helper cells with continued survival and differentiation signals preventing them from undergoing apoptosis due to lack of TCR signaling.[12] For example, IL-2 signaling in T cells upregulates the expression of anti-apoptotic protein Bcl-2, but T cell production of IL-2 and the high-affinity IL-2 receptor IL-2RA both require continued signal from TCR recognition of MHC-bound antigen.[9][16]

Macrophage Activation

[edit]

Macrophages can achieve different activation phenotypes through interactions with different subsets of T helper cells, such as TH1 and TH2.[17] Although there is a broad spectrum of macrophage activation phenotypes, there are two major phenotypes that are commonly acknowledged.[17] They are the classically activated macrophages, or M1 macrophages, and the alternatively activated macrophages, or M2 macrophages. M1 macrophages are proinflammatory, while M2 macrophages are mostly anti-inflammatory.[17]

Classical Macrophage Activation
[edit]

TH1 cells play an important role in classical macrophage activation as part of type 1 immune response against intracellular pathogens (such as intracellular bacteria) that can survive and replicate inside host cells, especially those pathogens that replicate even after being phagocytosed by macrophages.[18] After the TCR of TH1 cells recognize specific antigen peptide-bound MHC class II molecules on macrophages, TH1 cells 1) secrete IFN-γ and 2) upregulate the expression of CD40 ligand (CD40L), which binds to CD40 on macrophages.[19][9] These 2 signals activate the macrophages and enhance their ability to kill intracellular pathogens through increased production of antimicrobial molecules such as nitric oxide (NO) and superoxide (O2-).[20][9] This enhancement of macrophages' antimicrobial ability by TH1 cells is known as classical macrophage activation, and the activated macrophages are known as classically activated macrophages, or M1 macrophages. The M1 macrophages in turn upregulates B7 molecules and antigen presentation through MHC class II molecules to provide signals that sustain T cell help.[19] The activation of TH1 and M1 macrophage is a positive feedback loop, with IFN-γ from TH1 cells upregulating CD40 expression on macrophages; the interaction between CD40 on the macrophages and CD40L on T cells activate macrophages to secrete IL-12; and IL-12 promotes more IFN-γ secretion from TH1 cells.[9][19] The initial contact between macrophage antigen-bound MHC II and TCR serves as the contact point between the two cells where most of the IFN-γ secretion and CD-40L on T cells concentrate to, so only macrophages directly interacting with TH1 cells are likely to be activated.[9]

In addition to activating M1 macrophages, TH1 cells express Fas ligand (FasL) and lymphotoxin beta (LT-β) to help kill chronically infected macrophages that can no longer kill pathogens.[9] The killing of chronically infected macrophages release pathogens to the extracellular space that can then be killed by other activated macrophages.[9] TH1 cells also help recruit more monocytes, the precursor to macrophages, to the infection site. TH1 secretion TNF-α and LT-α to make blood vessels easier for monocytes to bind to and exit.[9] TH1 secretion of CCL2 as a chemoattractant for monocytes. IL-3 and GM-CSF released by TH1 cells stimulate more monocyte production in the bone marrow.[9]

When intracellular pathogens cannot be completely eliminated, such as in the case of Mycobacterium tuberculosis, the pathogen is contained through the formation of granuloma, an aggregation of infected macrophages surrounded by activated T cells.[21] The macrophages bordering the activated lymphocytes often fuse to form multinucleated giant cells that appear to have increased antimicrobial ability due to their proximity to TH1 cells, but over time, the cells in the center start to die and form necrotic tissue.[14][21]

Alternative Macrophage Activation
[edit]

TH2 cells play an important role in alternative macrophage activation as part of type 2 immune response against large extracellular pathogens like helminths.[9][22] TH2 cells secrete IL-4 and IL-13, which activate macrophages to become M2 macrophages, also known as alternatively activated macrophages.[22][23] M2 macrophages express arginase-1, an enzyme that converts arginine to ornithine and urea.[22] Ornithine help increase smooth muscle contraction to expel the worm and also participates in tissue and wound repair. Ornithine can be further metabolized to proline, which is essential for synthesizing collagen.[22] M2 macrophages can also decrease inflammation by producing IL-1 receptor antagonist (IL-1RA) and IL-1 receptors that do not lead to downstream inflammatory signaling (IL-1RII).[9][24]

Interactions with CD8+ Cytotoxic T Cells

[edit]

Another part of the adaptive immunity activation involves stimulating CD8+ via cross presentation of antigens peptides on MHC class I molecules. Studies have shown that proinflammatory macrophages are capable of cross presentation of antigens on MHC class I molecules, but whether macrophage cross-presentation plays a role in naïve or memory CD8+ T cell activation is still unclear.[2][25][15]

Interactions with B cells

[edit]

Macrophages have been shown to secrete cytokines BAFF and APRIL, which are important for plasma cell isotype switching. APRIL and IL-6 secreted by macrophage precursors in the bone marrow help maintain survival of plasma cells homed to the bone marrow.[26]

References

[edit]
  1. ^ a b c d e f Arango Duque, Guillermo; Descoteaux, Albert (2014-10-07). "Macrophage Cytokines: Involvement in Immunity and Infectious Diseases". Frontiers in Immunology. 5. doi:10.3389/fimmu.2014.00491. ISSN 1664-3224. PMC 4188125. PMID 25339958.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  2. ^ a b c d e Punt, Jenni; Stranford, Sharon; Jones, Patricia; Owen, Judy (May 25, 2018). Kuby Immunology (8th ed.). New York, New York: W. H. Freeman. ISBN 9781464189784.{{cite book}}: CS1 maint: year (link)
  3. ^ a b c Fu, Yan Lin; Harrison, Rene E. (2021-04-29). "Microbial Phagocytic Receptors and Their Potential Involvement in Cytokine Induction in Macrophages". Frontiers in Immunology. 12: 662063. doi:10.3389/fimmu.2021.662063. ISSN 1664-3224. PMC 8117099. PMID 33995386.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  4. ^ a b Hirayama, Daisuke; Iida, Tomoya; Nakase, Hiroshi (2017-12-29). "The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis". International Journal of Molecular Sciences. 19 (1): 92. doi:10.3390/ijms19010092. ISSN 1422-0067. PMC 5796042. PMID 29286292.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  5. ^ Uribe-Querol, Eileen; Rosales, Carlos (2020-06-02). "Phagocytosis: Our Current Understanding of a Universal Biological Process". Frontiers in Immunology. 11: 1066. doi:10.3389/fimmu.2020.01066. ISSN 1664-3224. PMC 7280488. PMID 32582172.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  6. ^ Law, S. K. Alex (1988-01-01). "C3 receptors on macrophages". Journal of Cell Science. 1988 (Supplement_9): 67–97. doi:10.1242/jcs.1988.Supplement_9.4. ISSN 1477-9137.
  7. ^ Forman, Henry Jay; Torres, Martine (2002-12-15). "Reactive Oxygen Species and Cell Signaling: Respiratory Burst in Macrophage Signaling". American Journal of Respiratory and Critical Care Medicine. 166 (supplement_1): S4–S8. doi:10.1164/rccm.2206007. ISSN 1073-449X.
  8. ^ Liu, Ting; Zhang, Lingyun; Joo, Donghyun; Sun, Shao-Cong (2017-07-14). "NF-κB signaling in inflammation". Signal Transduction and Targeted Therapy. 2 (1): 17023. doi:10.1038/sigtrans.2017.23. ISSN 2059-3635. PMC 5661633. PMID 29158945.{{cite journal}}: CS1 maint: PMC format (link)
  9. ^ a b c d e f g h i j k l m n o p q r Murphy, Kenneth; Weaver, Casey; Berg, Leslie (2022). Janeway's Immunobiology (10th ed.). New York, New York: W. W. Norton & Company. ISBN 9780393884876.
  10. ^ Eming, Sabine A.; Krieg, Thomas; Davidson, Jeffrey M. (2007-03). "Inflammation in Wound Repair: Molecular and Cellular Mechanisms". Journal of Investigative Dermatology. 127 (3): 514–525. doi:10.1038/sj.jid.5700701. {{cite journal}}: Check date values in: |date= (help)
  11. ^ Mezouar, Soraya; Mege, Jean-Louis (2020-07-01). "Changing the paradigm of IFN-γ at the interface between innate and adaptive immunity: Macrophage-derived IFN-γ". Journal of Leukocyte Biology. 108 (1): 419–426. doi:10.1002/JLB.4MIR0420-619RR. ISSN 0741-5400.
  12. ^ a b c Guerriero, Jennifer L. (2019), "Macrophages", International Review of Cell and Molecular Biology, vol. 342, Elsevier, pp. 73–93, doi:10.1016/bs.ircmb.2018.07.001, ISBN 978-0-12-815381-9, retrieved 2023-03-11
  13. ^ a b c Itano, Andrea A; Jenkins, Marc K (2003-08-01). "Antigen presentation to naive CD4 T cells in the lymph node". Nature Immunology. 4 (8): 733–739. doi:10.1038/ni957. ISSN 1529-2908.
  14. ^ a b c Murphy, Kenneth; Weaver, Casey (2016). Janeway's Immunobiology (9th ed.). New York, New York: Garland Science. pp. 363–364. ISBN 9780815345053.
  15. ^ a b Gray, Elizabeth E.; Cyster, Jason G. (2012). "Lymph Node Macrophages". Journal of Innate Immunity. 4 (5–6): 424–436. doi:10.1159/000337007. ISSN 1662-811X. PMC 3574571. PMID 22488251.{{cite journal}}: CS1 maint: PMC format (link)
  16. ^ Abbas, Abul K. (2020-09). "The Surprising Story of IL-2". The American Journal of Pathology. 190 (9): 1776–1781. doi:10.1016/j.ajpath.2020.05.007. {{cite journal}}: Check date values in: |date= (help)
  17. ^ a b c Mosser, David M.; Edwards, Justin P. (2008-12). "Exploring the full spectrum of macrophage activation". Nature Reviews Immunology. 8 (12): 958–969. doi:10.1038/nri2448. ISSN 1474-1733. PMC 2724991. PMID 19029990. {{cite journal}}: Check date values in: |date= (help)CS1 maint: PMC format (link)
  18. ^ Annunziato, Francesco; Romagnani, Chiara; Romagnani, Sergio (2015-03). "The 3 major types of innate and adaptive cell-mediated effector immunity". Journal of Allergy and Clinical Immunology. 135 (3): 626–635. doi:10.1016/j.jaci.2014.11.001. {{cite journal}}: Check date values in: |date= (help)
  19. ^ a b c Cai, Hao; Zhang, Yichi; Wang, Jian; Gu, Jinyang (2021-06-23). "Defects in Macrophage Reprogramming in Cancer Therapy: The Negative Impact of PD-L1/PD-1". Frontiers in Immunology. 12: 690869. doi:10.3389/fimmu.2021.690869. ISSN 1664-3224. PMC 8260839. PMID 34248982.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  20. ^ Arango Duque, Guillermo; Descoteaux, Albert (2014-10-07). "Macrophage Cytokines: Involvement in Immunity and Infectious Diseases". Frontiers in Immunology. 5. doi:10.3389/fimmu.2014.00491. ISSN 1664-3224. PMC 4188125. PMID 25339958.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  21. ^ a b Hilhorst, Marc; Shirai, Tsuyoshi; Berry, Gerald; Goronzy, Jörg J.; Weyand, Cornelia M. (2014). "T Cell–Macrophage Interactions and Granuloma Formation in Vasculitis". Frontiers in Immunology. 5. doi:10.3389/fimmu.2014.00432. ISSN 1664-3224. PMC 4162471. PMID 25309534.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  22. ^ a b c d Rolot, Marion; Dewals, Benjamin G. (2018-07-02). "Macrophage Activation and Functions during Helminth Infection: Recent Advances from the Laboratory Mouse". Journal of Immunology Research. 2018: 1–17. doi:10.1155/2018/2790627. ISSN 2314-8861. PMC 6051086. PMID 30057915.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  23. ^ Gordon, Siamon (2003-01-01). "Alternative activation of macrophages". Nature Reviews Immunology. 3 (1): 23–35. doi:10.1038/nri978. ISSN 1474-1733.
  24. ^ Peters, Vanessa A.; Joesting, Jennifer J.; Freund, Gregory G. (2013-08-01). "IL-1 receptor 2 (IL-1R2) and its role in immune regulation". Brain, Behavior, and Immunity. 32: 1–8. doi:10.1016/j.bbi.2012.11.006. PMC 3610842. PMID 23195532.{{cite journal}}: CS1 maint: PMC format (link)
  25. ^ Muntjewerff, Elke M.; Meesters, Luca D.; van den Bogaart, Geert (2020-07-08). "Antigen Cross-Presentation by Macrophages". Frontiers in Immunology. 11: 1276. doi:10.3389/fimmu.2020.01276. ISSN 1664-3224. PMC 7360722. PMID 32733446.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
  26. ^ Xu, Wei; Banchereau, Jacques (2014). "The Antigen Presenting Cells Instruct Plasma Cell Differentiation". Frontiers in Immunology. 4. doi:10.3389/fimmu.2013.00504. ISSN 1664-3224. PMC 3880943. PMID 24432021.{{cite journal}}: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)